Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis

被引:143
作者
Jian, B
Jones, PL
Li, QY
Mohler, ER
Schoen, FJ
Levy, RJ
机构
[1] Childrens Hosp Philadelphia, Cardiol Res Lab, Philadelphia, PA 19104 USA
[2] Univ Penn Hlth Syst, Dept Med, Philadelphia, PA USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1016/S0002-9440(10)61698-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We previously showed that the expression of tenascin (TN-C), an extracellular matrix glycoprotein found in developing bone and atherosclerotic plaque, and matrix metalloproteinase-2 (MMP-2) are coordinated and Interdependent in cultured vascular smooth muscle cells. In this study, we hypothesized that TN-C and MMP-2 are mechanistically involved in the pathobiology of calcific aortic stenosis. Human calcific aortic stenosis cusps demonstrated immunohistochemically prominent deposition of TN-C, MMP-2, and alkaline phosphatase activity, as well as MMP-2 gelatinolytic activity. Although far lesser amounts of TN-C were noted in several of the grossly non-calcified valve cusps, MMP-2 and AP were never detected. Further, when aortic valve interstitial cells (both sheep and human) were cultivated on collagen supplemented with TN-C, both MMP-2 mRNA expression and MMP-2 gelatinolytic activity (both pro and active forms), were up-regulated compared to control. These observations support the view that accumulation of first TN-C and then MMP-2 are associated with progression of calcification. The residual presence of these proteins in severe calcifications is indicative of their involvement in the pathogenesis.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 33 条
[1]  
ANDERSON HC, 1989, LAB INVEST, V60, P320
[2]  
Balica M, 1997, CIRCULATION, V95, P1954
[3]   Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis [J].
Bini, A ;
Mann, KG ;
Kudryk, BJ ;
Schoen, FJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (08) :1852-1861
[4]   BONE MORPHOGENETIC PROTEIN EXPRESSION IN HUMAN ATHEROSCLEROTIC LESIONS [J].
BOSTROM, K ;
WATSON, KE ;
HORN, S ;
WORTHAM, C ;
HERMAN, IM ;
DEMER, LL .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1800-1809
[5]  
Connolly JM, 1997, INT J ONCOL, V10, P71
[6]  
COWAN K, 1997, CIRCULATION S, V1, P243
[7]   Matrix metalloproteinase expression in nonrheumatic aortic stenosis [J].
Edep, ME ;
Shirani, J ;
Wolf, P ;
Brown, DL .
CARDIOVASCULAR PATHOLOGY, 2000, 9 (05) :281-286
[8]   TENASCIN - AN EXTRACELLULAR-MATRIX PROTEIN PROMINENT IN SPECIALIZED EMBRYONIC-TISSUES AND TUMORS [J].
ERICKSON, HP ;
BOURDON, MA .
ANNUAL REVIEW OF CELL BIOLOGY, 1989, 5 :71-92
[9]  
HURLE JM, 1990, ANAT EMBRYOL, V181, P149
[10]   Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system [J].
Jo, Y ;
Yeon, J ;
Kim, HJ ;
Lee, ST .
BIOCHEMICAL JOURNAL, 2000, 345 :511-519